These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2390375)
1. Comparative effects of a novel vitamin D analogue MC-903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity, osteocalcin and DNA synthesis by human osteoblastic cells in culture. Marie PJ; Connes D; Hott M; Miravet L Bone; 1990; 11(3):171-9. PubMed ID: 2390375 [TBL] [Abstract][Full Text] [Related]
2. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3. Evans DB; Thavarajah M; Binderup L; Kanis JA J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941 [TBL] [Abstract][Full Text] [Related]
3. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells. Valaja T; Mahonen A; Pirskanen A; Mäenpää PH Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591 [TBL] [Abstract][Full Text] [Related]
4. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3. Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186 [TBL] [Abstract][Full Text] [Related]
5. Synthetic 20-epi analogs of calcitriol are potent inducers of target-gene activation in osteoblastic cells. Ryhänen S; Mahonen A; Jääskeläinen T; Mäenpää PH Eur J Biochem; 1996 May; 238(1):97-103. PubMed ID: 8665957 [TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. Sterck JG; Klein-Nulend J; Burger EH; Lips P J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947 [TBL] [Abstract][Full Text] [Related]
7. Differentiation of heterogeneous phenotypes in human osteoblast cultures in response to 1,25-dihydroxyvitamin D3. Thavarajah M; Evans DB; Kanis JA Bone; 1993; 14(5):763-7. PubMed ID: 7505605 [TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta (TGF beta) and 1,25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Ingram RT; Bonde SK; Riggs BL; Fitzpatrick LA Differentiation; 1994 Jan; 55(2):153-63. PubMed ID: 8143932 [TBL] [Abstract][Full Text] [Related]
9. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3. Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311 [TBL] [Abstract][Full Text] [Related]
10. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells. Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350 [TBL] [Abstract][Full Text] [Related]
11. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462 [TBL] [Abstract][Full Text] [Related]
12. [Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts]. Pei Y; Zhou XY; Meng XW; Xia WB; Xing XP; Liu HC; Hu YY Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1084-8. PubMed ID: 12899784 [TBL] [Abstract][Full Text] [Related]
13. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related]
14. Changes in cytoskeletal proteins in response to parathyroid hormone and 1,25-dihydroxyvitamin D in human osteoblastic cells. Lomri A; Marie PJ Bone Miner; 1990 Jul; 10(1):1-12. PubMed ID: 2168775 [TBL] [Abstract][Full Text] [Related]
15. Effects of 1alpha,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-beta estradiol. Rao LG; Sutherland MK; Reddy GS; Siu-Caldera ML; Uskokovic MR; Murray TM Bone; 1996 Dec; 19(6):621-7. PubMed ID: 8968029 [TBL] [Abstract][Full Text] [Related]
16. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Kassem M; Kveiborg M; Eriksen EF Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903 [TBL] [Abstract][Full Text] [Related]
17. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
18. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. Spiess YH; Price PA; Deftos JL; Manolagas SC Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045 [TBL] [Abstract][Full Text] [Related]
19. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation. Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478 [TBL] [Abstract][Full Text] [Related]
20. Lead inhibits the basal and stimulated responses of a rat osteoblast-like cell line ROS 17/2.8 to 1 alpha,25-dihydroxyvitamin D3 and IGF-I. Angle CR; Thomas DJ; Swanson SA Toxicol Appl Pharmacol; 1990 Apr; 103(2):281-7. PubMed ID: 2330589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]